EUVIMEDEUVIMED entdecken
Crossref

Advances in the management of esophageal cancer

Bruce D. MINSKY

Marmara Medical Journal · 2015

DOI: 10.5472/mmj.10059 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marmara Medical Journal, 2015. Verfasst von Bruce D. MINSKY.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The management of clinical stage III and IVa esophagealcancer has evolved in the past 2 decades. Based on the Crosstrial, neoadjuvant chemoradiation, followed by surgicalresection has become standard. For medically inoperable,definitive chemoradiation is most commonly used. Thestandard radiation dose is 50.4 Gy although trials of doseescalationare ongoing. At the current time, there are nodefinitive biomarkers to predict response.Keywords: Esophageal cancer, Radiation therapy,Chemotherapy, Dose-escalation

Zitieren

APA

MINSKY, B. D. (2015). Advances in the management of esophageal cancer. Marmara Medical Journal. https://doi.org/10.5472/mmj.10059

Vancouver

MINSKY BD. Advances in the management of esophageal cancer. Marmara Medical Journal. 2015. doi:10.5472/mmj.10059

BibTeX
@article{MINSKY2015,
  author = {MINSKY, Bruce D.},
  title = {Advances in the management of esophageal cancer},
  journal = {Marmara Medical Journal},
  year = {2015},
  doi = {10.5472/mmj.10059}
}
Kostenlos starten →